NCT06604338

Brief Summary

Recurrent pregnancy losses (RPL) are characterized by the occurrence of more than one spontaneous pregnancy loss. It is caused by different known factors, but about half of the cases remain without an explanation. Efforts are being done in the scientific community to solve this cases. In this study, the investigators aim to investigate genetic factors that might predispose to RPL, as well as the influence of the uterine microbiota (microorganisms that normally live in the uterus of women).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 14, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.2 years

First QC Date

September 9, 2024

Last Update Submit

September 17, 2024

Conditions

Keywords

MiscarriageRecurrent miscarriageAbortionRecurrent abortionGenetic susceptibilityMicrobiome

Outcome Measures

Primary Outcomes (2)

  • Microbiome

    The participants microbiome will be evaluated aiming to compare the species profile between cases and controls. The bacteria present in the microbiome will be described at the genus and species level.

    At the time of enrollment

  • Exome

    The participants exomes will be evaluated to look for variants in specific genes, aiming to identify rare variants that will be compared with frequencies from population genomic databases. The impact of the identified variants on proteins will be assessed through in silico functional predictors.

    At the time of enrollment

Study Arms (2)

RPL group

The RPL group will include women with a history of at least two spontaneous pregnancy losses, regardless of whether they have living children, and whose etiology for the pregnancy losses was not determined by the care team's protocols.

Diagnostic Test: Exome testDiagnostic Test: Microbiota analysis

Control group

Women with at least two full-term pregnancies and no history of difficulty getting pregnant, pregnancy loss or other infertility factors will be enrolled in the control group.

Diagnostic Test: Microbiota analysis

Interventions

Exome testDIAGNOSTIC_TEST

An exome will be performed on the participants of RPL group.

RPL group
Microbiota analysisDIAGNOSTIC_TEST

A cervical microbiota analysis will be performed in the RPL and control groups.

Control groupRPL group

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women who seek the Gynecology and Obstetrics Service of the Hospital de Clínicas de Porto Alegre (HCPA) for care and investigation of causes of infertility or for exams not related to this condition will be included in the study.

You may qualify if:

  • RPL group: history of at least two spontaneous pregnancy losses, regardless of whether they have living children, and whose etiology for the pregnancy losses was not determined by the care team\'s protocols;
  • Control group: at least two full-term pregnancies and no history of difficulty getting pregnant, pregnancy loss or other infertility factors.

You may not qualify if:

  • RPL group: less than two spontaneous pregnancy losses and those with a known cause for repeated pregnancy losses;
  • Control group: N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clínicas de Porto Alegre (HCPA)

Porto Alegre, Rio Grande do Sul, 90410-000, Brazil

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral blood and cervical samples

MeSH Terms

Conditions

Abortion, SpontaneousAbortion, HabitualGenetic Predisposition to Disease

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDisease SusceptibilityDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lucas Rosa Fraga, PhD, Professor

    Hospital de Clínicas de Porto Alegre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lucas Rosa Fraga, PhD, Professor

CONTACT

Luiza Pretto, PhD Student

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

April 14, 2023

Primary Completion

July 5, 2024

Study Completion

December 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations